Le Lézard
Classified in: Health
Subject: AWD

Clearview Horizon Achieves Behavioral Health Care Accreditation from The Joint Commission


HERON, Mont., Jan. 18, 2018 /PRNewswire/ -- Clearview Horizon today announced it has earned The Joint Commission's Gold Seal of Approval® for Behavioral Health Care Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval® is a symbol of quality that reflects an organization's commitment to providing safe and effective care.

Clearview Horizon (https://www.clearviewhorizon.com) underwent a rigorous on-site survey beginning on December 13, 2017. During the review, compliance with behavioral health care standards related to several areas, including care, treatment, and services; environment of care; leadership; and screening procedures for the early detection of imminent harm was evaluated. On-site observations and interviews also were conducted.

Established in 1969, The Joint Commission's Behavioral Health Care Accreditation Program currently accredits more than 2,250 organizations for a three-year period. Accredited organizations provide treatment and services within a variety of settings across the care continuum for individuals who have mental health, addiction, eating disorder, intellectual/developmental disability, and/or child-welfare related needs.

"Joint Commission accreditation provides behavioral health care organizations with the processes needed to improve in a variety of areas related to the care of individuals and their families," said Julia Finken, RN, BSN, MBA, CSSBB, CPHQ, executive director, Behavioral Health Care Accreditation Program, The Joint Commission. "We commend Clearview Horizon for its efforts to elevate the standard of care it provides and to instill confidence in the community it serves."

"Clearview Horizon, located near Sandpoint, Idaho, is pleased to receive Behavioral Health Care Accreditation from The Joint Commission, the premier health care quality improvement and accrediting body in the nation," added Mike Linderman, Clearview's Executive Clinical Director. "Our team continues to work together to develop and implement approaches and strategies that have the potential to improve care for the community that we serve."

The Joint Commission's behavioral health care standards are developed in consultation with health care experts and providers, quality improvement measurement experts, and individuals and their families. The standards are informed by scientific literature and expert consensus to help organizations measure, assess and improve performance.

Contact:
Jason W. Thielbahr
Chief Financial Officer
(509) 723-7251
[email protected]

Clearview Horizon Therapeutic Boarding School (https://www.clearviewhorizon.com)

SOURCE Clearview Horizon - Therapeutic Boarding School


These press releases may also interest you

at 18:16
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 17:56
The Canadian Cancer Society commends the increases in taxes on tobacco and e-cigarettes in today's federal budget.  The budget increases tobacco taxes by $4.00 per carton of 200 cigarettes effective at midnight, and increases e-cigarette taxes by 12%...

at 17:45
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to...

at 17:31
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering...

at 17:26
Amgen today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American...

at 17:05
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Toronto Stock Exchange ("TSX") is reviewing the eligibility for continued listing on the TSX of the securities of the Company. The TSX has identified the Company's financial...



News published on and distributed by: